The PinPoint Test
AI-enabled blood testing for cancer
The PinPoint Test is an AI-driven blood test for cancer that plugs into healthcare systems like an app.
It unlocks the data in your blood to make sure you get the help you need when you need it most.
Machine learning does what no human can – it analyses 32 biomarkers all at once, measuring how they interact and how they relate to cancer risk, then combines these signals into ONE simple result: the chance a patient has cancer.
The result is a tool for intelligent triage
Extra certainty for doctors to either rule cancer out and look at other possible diagnoses, or to refer directly for investigation as a faster route to diagnosis and treatment.
What Makes the PinPoint Test Different?
Choose one of the options below to see how PinPoint can help you.
PinPoint is designed to help you when you need it most.
If you have symptoms like unexplained weight loss, fatigue, a lump or pain that doesn’t go away, a GP or family doctor’s job is to decide what the likely cause is, but symptoms can be vague and difficult to read.
PinPoint helps by pointing you in the right direction sooner – a route to the care you need, based on your personal risk for cancer.
Some testing for cancer involves a trip to hospital, some is invasive, uncomfortable or can even bring risk of harm. Statistics show that whatever the reason, not everyone can or wants to take part in early cancer testing, some simply aren’t aware of the signs or what help is available.
PinPoint is a simple blood test...
… just like any other blood test you’ve had before – quick, easy and pain-free. It can be done at your local GP, clinic or even at home, meaning equal access to multi-cancer testing for us all.
PinPoint makes decision making around cancer risk easier for you, the attending clinician.
It offers peace of mind that your patient will get the right diagnosis faster, whether that be expedited investigation and treatment or ruling cancer out early so they can be safety netted and alternative diagnoses explored.
Adding one quick, standard blood test to the diagnostic workup when a patient first presents with symptoms offers two critical benefits:
- Fewer missed cancers and faster investigation for patients that need it;
- Reduced over-testing and anxiety for patients that don’t.
PinPoint achieves these goals with minimal additional burden on workflow.
Greater certainty around early-stage symptoms will mean fewer repeat appointments for patients presenting with vague symptoms and for patients bounced back to their family doctor after negative test results in hospital.
Cancer detection is like finding the proverbial needle in the haystack.
3 million symptomatic patients received NHS urgent suspected cancer referrals in England in 2023-24 – only 6% had cancer. It’s even harder when the patient is non-symptomatic.
PinPoint makes it possible to run more efficient cancer diagnostic services with resources focused on those at greatest risk.
- Improved patient experience: peace of mind from more accurate rule-out and flagging of high risk. Fewer unnecessary invasive tests for non-cancer patients and reassurance that when you do need it, you’ll get the support you need faster.
- Greater certainty for the referring clinician, safe in the knowledge that patients are being recommended the best course of action, be that further investigation or safety netting and monitoring.
- More efficient and impactful cancer services made easier for the healthcare provider. PinPoint represents a cost-effective route to better patient care – an AI-upgrade to standard testing that puts you one step ahead of competitors.
- Insurance providers can better control the allocation of resources through the use of PinPoint intelligent triage. Rule-out reduces the number of diagnostic tests required, without increasing the risk of missed cancers.
In short, PinPoint makes doing the right thing for the patient easier, quicker and more cost-effective.
Equal opportunity for everyone
Early cancer detection is important for everyone. The earlier you are diagnosed, the better your chances of beating the disease. But access to early testing isn’t always a level playing field.
Elderly and frail people
Elderly and frail people can struggle physically to do some tests and are at increased risk of harm from things like endoscopy.
People with visual impairments
People with visual impairments may need help to do at-home tests or get to appointments.
Cultural factors
Cultural or religious factors may mean people are unable to do certain tests or health checks, e.g. gynaecological or colorectal.
People living in remote locations
People living in remote locations or without access to transport may not be able to attend hospital appointments.
People living in a new country
People living in a new country may face language barriers and simply not be aware of what symptoms to look for or what services are available to them.
Elderly and frail people
Elderly and frail people can struggle physically to do some tests and are at increased risk of harm from things like endoscopy.
People with visual impairments
People with visual impairments may need help to do at-home tests or get to appointments.
Cultural factors
Cultural or religious factors may mean people are unable to do certain tests or health checks, e.g. gynaecological or colorectal.
People living in remote locations
People living in remote locations or without access to transport may not be able to attend hospital appointments.
People living in a new country
People living in a new country may face language barriers and simply not be aware of what symptoms to look for or what services are available to them.